Human Chorionic Gonadotropin (HCG)


Article Author:
Danielle Betz


Article Editor:
Kathleen Fane


Editors In Chief:
Michelle Miranda


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Frank Smeeks
Kristina Soman-Faulkner
Trevor Nezwek
Radia Jamil
Patrick Le
Sobhan Daneshfar
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Navid Mahabadi
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
1/16/2019 9:52:35 AM

Introduction

Human chorionic gonadotropin (hCG) is a chemical created by trophoblast tissue, tissue typically found in early embryos and which will eventually be part of the placenta. Measuring hCG levels can be helpful in identifying a normal pregnancy, pathologic pregnancy, and can also be useful following an aborted pregnancy. There is also a benefit in measuring hCG in a variety of cancers including choriocarcinoma and extra-uterine malignancies.

Etiology and Epidemiology

Human chorionic gonadotropin is a hormone produced primarily by syncytiotrophoblastic cells of the placenta during pregnancy. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy. Smaller amounts of hCG are also produced in the pituitary gland, the liver, and the colon.[1] As previously mentioned, certain malignancies can also produce either hCG or hCG-related hormone. Trophoblastic cancers (hydatidiform mole, choriocarcinoma, and germ cell tumors) are associated with high serum levels of hCG-related molecules.

The hormone itself is a glycoprotein composed of two subunits, the alpha and beta subunits.[1] There are multiple forms found in the serum and urine during pregnancy including the intact hormone and each of the free subunits. HCG is primarily catabolized by the liver, although about 20% is excreted in the urine. The beta subunit is degraded in the kidney to make a core fragment which is measured by urine hCG tests.

Specimen Requirements and Procedure

Urine Testing

  • Urine should not be collected after the patient has been drinking a large amount of fluid, as a dilute specimen may result in a falsely negative test.[2]
  • Blood in the urine may cause a false positive test result.

Serum Testing

  • Peripheral blood can be obtained for a serum hCG test.

Diagnostic Tests

Serum tests for hCG are immunometric assays. This means that they use 2two antibodies that bind to the hCG molecule, a fixed antibody and a radiolabeled antibody which adhere to different sites on the molecule, sandwiching and immobilize the molecule to make it detectable.[3] Assays involve washing away the excess serum components and measuring the amount of remaining labeled hCG to give a quantitative result. There are more than 100 different assays commercially available which results in significant variability in reported values.

Urine assays are similar, although many detect total hCG levels greater than 20 mIU/mL.[4] Many over-the-counter urine pregnancy tests do not detect hyperglycosylated hCG, which accounts for most of the hCG in early pregnancy, resulting in a wide range of sensitivities of these tests.

Serum testing is much more sensitive and specific than urine testing. Urine testing, however, is more convenient, affordable, comfortable for patients, has a fast turnaround (5 to 10 minutes), and does not require a medical prescription.

Testing Procedures

Urine Testing

  • Urine is placed in or on a designated receptacle (most commercially available and medical point of care tests)
  • An indicator (typically a colored line or symbol), along with a control, will appear if the test is positive
  • An isolated control line/symbol will be evident if the test is negative

Serum Testing

  • Serum hCG testing is performed in a laboratory equipped with the proper machinery and uses a peripheral blood sample
  • If a hook effect/gestational trophoblastic disease is suspected, the lab should perform a dilution prior to testing

Interfering Factors

There are multiple reasons why an hCG test (serum or urine) may have a false report. While uncommon, false positive hCG tests can result in unnecessary medical care and/or irreversible surgical procedures. False negatives may be equally concerning and result in a delay in care or diagnostic evaluation. Potential causes of false results are listed and briefly discussed.

Serum False Positives (1/1000 to 1/10,000)[5]

  • Ectopic production of hCG (hydatidiform mole, choriocarcinoma, and germ cell tumors,[6], in addition to multiple myeloma, stomach, liver, lung, bladder, pancreatic, breast, colon, cervical, and endometrial cancers)[7][8][9][10][11]
  • Heterophile antibodies (autoantibodies and antibodies formed after exposure to animal products that interact with the assay antibodies)[12][13]
  • Rheumatoid factors (can bind the antibodies in the assay as well)
  • IgA deficiency[14]
  • Chronic renal failure or ESRD on hemodialysis (rare)[15]
  • Red blood cell or plasma transfusion of blood with hCG in it have been reported
  • Exogenous hCG preparations for weight loss, assisted reproduction, doping[16]

Serum False Negatives

  • Early measurement after conception 
  • "Hook effect" can occur when hCG levels are about 500,000 mIU/mL.[17] This is because there are so many hCG molecules that they saturate both the tracer and the antibodies separately, which doesn't allow for the sandwiching of the tracer-hCG-antibody required for the measurement. This means that all of the complexes are washed away, giving a false-negative result. If gestational trophoblastic disease is suspected, the lab should perform a dilution prior to testing.

Urine False Positives

  • Blood or protein in the urine
  • Human error in result interpretation
  • Ectopic production of hCG
  • Exogenous hCG
  • Drugs (aspirin, carbamazepine, methadone, high urinary pH and seminal fluid)[18]

Urine False Negatives

  • Early measurement after conception
  • Dilute urine specimen[2]
  • "Hook effect" as discussed above

Results, Reporting, Critical Findings

HCG levels are reported in milli-international units of hCG hormone per milliliter of blood, or mIU/mL. International unit per liter (IU/L) may also be used.

Urine hCG testing is qualitative, reporting a positive or negative result. The assays detect hCG levels typically starting at 20 to 50 (reportedly as low as 6.3 to 12.5)[19] mIU/mL, corresponding to levels at approximately 4 weeks post-conception. 

Serum assays can measure beta-hCG as low as 1 to 2 mIU/mL.

Clinical Significance

Pregnancy

HCG is an important hormone in pregnancy, and its clinical utility is primarily centered around its detection in early pregnancy, along with serial measurement during pregnancy and pregnancy-related complications.

Levels of hCG can vary widely between women with normal pregnancies. Typically, serum and urine concentrations of hCG rise exponentially in the first trimester of pregnancy, doubling about every 24 hours during the first 8 weeks. The peak is usually around 10 weeks of gestation and then levels decrease until about the 16th week of gestation where they remain fairly constant until term.[3]

Patients who have hCG levels that plateau prior to 8 weeks or that fail to double commonly have a nonviable pregnancy, whether intra-uterine or extra-uterine. Extra-uterine (ectopic) pregnancies usually have a rate-of-rise that is low without the typical doubling. However, given the large range of normal hCG levels and inconsistent rates-of-rise of this hormone, checking serum levels is typically paired with ultrasound evaluation to improve sensitivity and specificity.[20]

Return of hCG to zero following delivery or termination of pregnancy ranges from 7 to 60 days.[21] Trending the fall of hCG levels can be important in termination of molar pregnancies and also following the termination of normal or ectopic pregnancies to be assured that the therapy has been successful.

It notable that there are many different combinations of antibodies used in commercial assays. This results in heterogeneous results with as much as a 50-fold difference in immunoassay results.[3] This is clinically relevant, particularly when comparing results from different laboratories in different facilities/hospitals when examining low values following pregnancy termination or trophoblastic disease.

Gestational Trophoblastic Disease

Detection of hCG is also useful in the evaluation of trophoblastic disease, including complete and partial hydatidiform mole, postmolar tumor, gestational choriocarcinoma, testicular choriocarcinoma, and placental site trophoblastic disease. All of these entities produce hCG, varying levels of which are reported on commercial assays. A total hCG level of greater than 100,000 mIU/mL in early pregnancy, for example, is highly suggestive of a complete hydatidiform mole,[22] although many normal pregnancies may reach this level at their peak around weeks 8 to 11 of gestation. Precise hCG measurements are important to assess the tumor mass, the successful treatment of malignancy, and to test for recurrence or persistence of disease.[6]

Non-Pregnant Patients

HCG in the serum increases with age in nonpregnant women. A cut off of 14 mIU/mL has been suggested for use in interpreting results in women over the age of 55. In all nonpregnant patients, testicular cancer, ovarian cancer, bladder cancer, or other malignancy should be evaluated as a source of persistently positive hCG testing.

Enhancing Healthcare Team Outcomes

Knowing the utility and variability of different hCG assays is clinically relevant to a wide range of medical providers. False positive and false negative testing has a large impact on patient care. All providers in a patient care team should be aware of common limitations in testing, for example, urine assay false positives with hematuria, false negatives with dilute urine, along with more obscure but still very relevant causes of inaccurate testing. Interpreting results that may be false should be undergone with care to help prevent unnecessary testing and treatment.[23] (Level V) Collaboration, shared decision making, and communication are critical elements in good patient care.


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Human Chorionic Gonadotropin (HCG) - Questions

Take a quiz of the questions on this article.

Take Quiz
What is the first placental hormone?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Beta-HCG testing is used to test for what condition?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 17-year-old female presents with a positive urine pregnancy test and vaginal spotting. Which method is used to assess fetal viability with the presence of first-trimester bleeding?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 29-year-old female who is in the sixth week of her pregnancy based on her last menstrual period comes for a routine prenatal visit. She would like to have an ultrasound done to make sure she has a viable pregnancy. At what minimum level of human chorionic gonadotrophin will ultrasound most likely show a gestational sac?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A woman with pelvic pain and a positive urine pregnancy test comes to the emergency department for evaluation. Her last menstrual period was 5 weeks ago. Which of the following is true regarding a serum beta-hCG level?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Human Chorionic Gonadotropin (HCG) - References

References

Human chorionic gonadotropin in pregnancy diagnostics., Montagnana M,Trenti T,Aloe R,Cervellin G,Lippi G,, Clinica chimica acta; international journal of clinical chemistry, 2011 Aug 17     [PubMed]
Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites., Cole LA,, Clinical chemistry, 1997 Dec     [PubMed]
Human anti-animal antibody interferences in immunological assays., Kricka LJ,, Clinical chemistry, 1999 Jul     [PubMed]
Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency., Knight AK,Bingemann T,Cole L,Cunningham-Rundles C,, Clinical and experimental immunology, 2005 Aug     [PubMed]
False-positive human chorionic gonadotropin levels caused by a heterophile antibody with the immunoradiometric assay., Check JH,Nowroozi K,Chase JS,Lauer C,Elkins B,Wu CH,, American journal of obstetrics and gynecology, 1988 Jan     [PubMed]
Human chorionic gonadotropin testing for early pregnancy viability and complications., Davies S,Byrn F,Cole LA,, Clinics in laboratory medicine, 2003 Jun     [PubMed]
Braunstein GD, False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition. American journal of obstetrics and gynecology. 2002 Jul     [PubMed]
Cole LA,Shahabi S,Butler SA,Mitchell H,Newlands ES,Behrman HR,Verrill HL, Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clinical chemistry. 2001 Feb     [PubMed]
Marcillac I,Troalen F,Bidart JM,Ghillani P,Ribrag V,Escudier B,Malassagne B,Droz JP,Lhommé C,Rougier P, Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer research. 1992 Jul 15     [PubMed]
Alfthan H,Haglund C,Roberts P,Stenman UH, Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer research. 1992 Sep 1     [PubMed]
Sheaff MT,Martin JE,Badenoch DF,Baithun SI, beta hCG as a prognostic marker in adenocarcinoma of the prostate. Journal of clinical pathology. 1996 Apr     [PubMed]
Lundin M,Nordling S,Carpelan-Holmstrom M,Louhimo J,Alfthan H,Stenman UH,Haglund C, A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer. Anticancer research. 2000 Nov-Dec     [PubMed]
Reisenbichler ES,Krontiras H,Hameed O, Beta-human chorionic gonadotropin production associated with phyllodes tumor of the breast: an unusual paraneoplastic phenomenon. The breast journal. 2009 Sep-Oct     [PubMed]
Greene DN,Schmidt RL,Kamer SM,Grenache DG,Hoke C,Lorey TS, Limitations in qualitative point of care hCG tests for detecting early pregnancy. Clinica chimica acta; international journal of clinical chemistry. 2013 Jan 16     [PubMed]
Griffey RT,Trent CJ,Bavolek RA,Keeperman JB,Sampson C,Poirier RF,     [PubMed]
Ong S,Beebeejaun H, The effect of physiological urine dilution on pregnancy test results in complicated early pregnancies. British journal of obstetrics and gynaecology. 1999 Jan     [PubMed]
Chard T, Pregnancy tests: a review. Human reproduction (Oxford, England). 1992 May     [PubMed]
Delbeke FT,Van Eenoo P,De Backer P, Detection of human chorionic gonadotrophin misuse in sports. International journal of sports medicine. 1998 May     [PubMed]
Fahy BG,Gouzd VA,Atallah JN, Pregnancy tests with end-stage renal disease. Journal of clinical anesthesia. 2008 Dec     [PubMed]
Cervinski MA,Lockwood CM,Ferguson AM,Odem RR,Stenman UH,Alfthan H,Grenache DG,Gronowski AM, Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clinica chimica acta; international journal of clinical chemistry. 2009 Aug     [PubMed]
Butts SF,Guo W,Cary MS,Chung K,Takacs P,Sammel MD,Barnhart KT, Predicting the decline in human chorionic gonadotropin in a resolving pregnancy of unknown location. Obstetrics and gynecology. 2013 Aug     [PubMed]
Menczer J,Modan M,Serr DM, Prospective follow-up of patients with hydatidiform mole. Obstetrics and gynecology. 1980 Mar     [PubMed]
Cole LA, Phantom hCG and phantom choriocarcinoma. Gynecologic oncology. 1998 Nov     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Nurse-Maternal Newborn RN. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Nurse-Maternal Newborn RN, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Nurse-Maternal Newborn RN, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Nurse-Maternal Newborn RN. When it is time for the Nurse-Maternal Newborn RN board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Nurse-Maternal Newborn RN.